Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status.

Tumour Biol · 2011 · PMC3093541 · PMID 21350924

Europe PMC DOI

hedged sentences

0.0480

closest p · 1.0× alpha

0.0620

boldest claim

The sentences

borderline significantp = 0.048actually significant

A borderline significant finding indicated that patients aged ≤60 years had higher tumor cell endoglin expression in effusions compared to older patients ( p = 0.048).

also in 11,409 other papers

showed a trendp = 0.062so close (0.05 < p ≤ 0.1)

Separate analysis with respect to treatment with a platinum agent (data available for 210/211 patients) showed a trend for higher tumor cell endoglin expression in effusions obtained after platinum treatment compared to effusions obtained at diagnosis, prior to treatment ( p = 0.062), while mesothelial cells showed significantly higher staining in effusions obtained prior to treatment with a platinum compound ( p = 0.019).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.